CPG for Psychosocial Interventions in Severe Mental ... - GuÃaSalud

More documents

Recommendations

Info

Appendix 7. Declaration of interest All the members of the development team, expert collaborators and external reviewers have declared no conflict of interest. Milagros Escusa Julián, Francisco Galán Calvo, Laura Gracia López, Pedro Pibernat Deulofeu, Ana Vallespí Cantabrana, Juan Ignacio Martín Sánchez, Maria José Vicente Edo, José Mª Álvarez Martínez, Daniel Navarro Bayón, Antonio Lobo Satué, Julián Carretero Román, Carlos Cuevas Yust, Begoña Iriarte Campo, Juan Francisco Jiménez Estévez, José Manuel Lalana Cuenca, Marcelino López Álvarez, Mercedes Serrano Miguel, Catalina Sureda García, Oscar Vallina Fernández, have declared no interests. Francisco Caro Rebollo has received funding (Janssen, Boehringer Ingelheim, Lundbeck, GSK and Novartis) for attending meetings, courses and congresses. He has obtained fees (Janssen) as a speaker at courses and conferences. He has also received economic aid to participate in research projects (Bristol Myers-Squibb, AstraZeneca, Esteve / Novartis, Janssen, Lilly. Concepción de la Cámara Izquierdo has received funding for attending meetings, courses and congresses (Esteve, Boerhringer, Pfizer, Janssen, Almirall, Boehringer Ingelheim). She has obtained fees as a speaker at courses and conferences (Andromaco, Bexal and Janssen). Andrés Martín Gracia has received funding for meetings, congresses and for attending courses (Boehringer Ingelheim, GSK, Janssen) and fees as a speaker at conferences and courses (Pfizer and Lilly). He has also received funding for educational programmes or courses (Janssen). Miguel Martínez Roig has obtained financing for participating in meetings, congresses and courses (Almirall, Janssen, Lundbeck, Lilly, Boheringer, Bristol-Myer, Wyeth). He has also received economic support to participate in research projects (Lilly, Pfizer and Janssen). Mª Esther Samaniego de Corcuera has received funding for participating in meetings, congresses and courses (Lilly). Fernando Cañas de Paz has received funding (Servier, Lundbeck and Janssen) to attend to meetings, courses and congresses, and for participating in research projects. He has also received fees as a speaker (Janssen, BMS) and for consultancy work (Janssen). Mª Consuelo Carballal Balsa has received funding for participating in courses, conferences and meetings (Janssen). Alberto Fernández Liria has received support (Janssen) to participate in conferences and fees as a speaker (Lilly, Bristol-Myers Squibb, Wyeth and Lundbeck). He has also received funding for participating in research projects (Wyeth, Pharma Consult Services). Miguel Bernardo Arroyo has received fees as a speaker (Lilly, BMS, Wyeth, Janssen and Pfizer). He has also received economic aid to finance research (BMS) and educational programmes or courses (Pfizer). Manuel Camacho Laraña has received economic support to finance his participation in conferences (Janssen, Lilly and GSK); and fees as a speaker (GSK and AstraZeneca). Juan José Uriarte Uriarte has obtained funding to participate in a congress and in a research project (AstraZeneca). 142 CLINICAL PRACTICE GUIDELINES IN THE SPANISH NHS
Bibliography 1 Parabiaghi A, Bonetto C, Ruggeri M, Lasalvia A, Leese M. Severe and persistent mental illness: a useful defi nition for prioritizing community-based mental health service interventions. Soc Psychiatry Psychiatr Epidemiol. 2006;41(6):457-63. 2 Schinnar AP, Rothbard AB, Kanter R, Jung YS. An empirical literature review of defi nitions of severe and persistent mental illness. Am J Psychiatry. 1990;147(12):1602-8. 3 Estrategia en salud mental del Sistema Nacional de Salud 2006. Madrid: Ministerio de Sanidad y Consumo; 2007. 4 National Institute of Mental Health. Towards a model for a comprehensive community based mental health system. Washington DC: NIMH; 1987. 5 Grupo de trabajo sobre GPC. Elaboración de guías de práctica clínica en el Sistema Nacional de Salud: manual metodológico. Madrid: Plan Nacional para el SNS del MSC. Instituto Aragonés de Ciencias de la Salud I+CS; 2007. Guías de Práctica Clínica en el SNS: I+CS Nº 2006/01. 6 Scottish Intercollegiate Guidelines Network. SIGN 50: a guideline developer’s handbook. Edinburgh: SIGN; 2008. 7 NICE. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care. London: National Institute for Health and Clinical Excellence; 2006. Nice Clinical Guideline, 38. 8 NICE, National Collaborating Centre for Mental Health. Schizophrenia: full national clinical guideline on core interventions in primary and secondary care. London: Gaskell, The Royal College of Psychiatrists; 2003. 9 NICE. Obsessive-compulsive disorder: core interventions in the treatment obsessive-compulsive disorder and body dysmorphic disorder. London: National Institute for Health and Clinical Excellence; 2005. NICE Clinical Guideline, 31. 10 NICE. Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (update) [Borrador en Internet]. London: NICE, 2008 [consultado 20 noviembre 2008]. Disponible en: http://www.nice.org.uk/guidance/index.jsp?a ction=download&o=42139. 11 Gisbert C, Arias P, Camps C, Cifre A, Chicharro F, Fernández J, et al. Rehabilitación psicosocial del trastorno mental severo: situación actual y recomendaciones. Madrid: Asociación Española de Neuropsiquiatría; 2002. Cuadernos Técnicos, n. 6. 12 CIE-10 Clasifi cación estadística internacional de enfermedades y problemas relacionados con la salud. 10ª ed. rev. Washington: Organización Mundial de la Salud; 2003. 13 Barrowclough C, Haddock G, Lobban F, Jones S, Siddle R, Roberts C, et al. Group cognitivebehavioural therapy for schizophrenia: randomised controlled trial. Br J Psychiatry. 2006;189: 527-32. 14 López M, Laviana M. Rehabilitación, apoyo social y atención comunitaria a personas con trastorno mental grave: propuestas desde Andalucía. Rev Asoc Esp Neuropsiq. 2007;27(99):187-223. CLINICAL PRACTICE GUIDELINES FOR PSICHOSOCIAL INTERVENTIONS IN SEVERE MENTAL ILLNESS 143
Page 1:
Clinical Practice Guidelines for Ps
Page 4 and 5:
This CPG is an aid for decision mak
Page 7 and 8:
Table of Contents Presentation 7 Au
Page 9 and 10:
Presentation Healthcare practice is
Page 11 and 12:
Authorship and collaborators CPG de
Page 13:
José Manuel Lalana Cuenca. Special
Page 16 and 17:
c) SERVICE LEVEL INTERVENTIONS •
Page 18 and 19:
A B A A B B B C Psychosocial inter
Page 20 and 21:
B B B C A C C 5.3. SERVICE LEV
Page 22 and 23:
20 CLINICAL PRACTICE GUIDELINES IN
Page 24 and 25:
independence, quality of life, pers
Page 26 and 27:
This guideline is aimed at mental h
Page 28 and 29:
Figure 1. Search Strategy Search fo
Page 30 and 31:
The highest evidence level found wa
Page 33 and 34:
4. Characteristics of the CPG 4.1.
Page 35 and 36:
The main focus of rehabilitation is
Page 37 and 38:
5. Psychosocial type rehabilitation
Page 39 and 40:
From another point of view, social
Page 41 and 42:
defined as “standard care” or
Page 43 and 44:
General global state In the short r
Page 45 and 46:
Specific symptoms: when CBT was com
Page 47 and 48:
In the systematic review by Kurtz a
Page 49 and 50:
Summary of evidence 1- 1- 1- 1- 1-
Page 51 and 52:
People with SMI and a diagnosis of
Page 53 and 54:
5.1.3. Interpersonal therapy The li
Page 55 and 56:
weekly or fortnightly sessions. The
Page 57 and 58:
5.1.5. Family interventions There a
Page 59 and 60:
In the RCT carried out by Hogarty e
Page 61 and 62:
A family intervention of more than
Page 63 and 64:
After two years’ treatment, and b
Page 65 and 66:
Family intervention vs. other psych
Page 67 and 68:
1- 1- 1- 1- 1- 1- 1- 1- 1+ No diffe
Page 69 and 70:
Question to be answered • Are pys
Page 71 and 72:
Summary of evidence Pyschoeducation
Page 73 and 74:
with schizophrenia and that the tre
Page 75 and 76:
With reference to the type of train
Page 77 and 78:
would normally receive and which in
Page 79 and 80:
Hypnosis vs. relaxation No improvem
Page 81 and 82:
Supervised fl ats are a community h
Page 83 and 84:
3 Programmes directed to leisure an
Page 85 and 86:
SMI (schizophrenia, affective schiz
Page 87 and 88:
When PVT is compared with standard
Page 89 and 90:
Patients included in the individual
Page 91 and 92:
1+ 1+ 1++ 1+ 1+ 1+ 1+ The people in
Page 93 and 94: Music therapy Music therapy + stand
Page 95 and 96: A series of Case Management systems
Page 97 and 98: • The satisfaction data originati
Page 99 and 100: Loss of contact With respect to the
Page 101 and 102: There is not sufficient evidence, e
Page 103 and 104: 1+ 1+ 1+ 1+ Respect to ICM teams or
Page 105 and 106: Finally, in the RCT by Cheng et al
Page 107 and 108: 5.4.2. “Homeless” with SMI The
Page 109 and 110: Patients who access housing with no
Page 111: ceptive disorders. This series of c
Page 115 and 116: 7. Recommendations for Future Resea
Page 117: Appendices
Page 120 and 121: Appendix 2. Information obtained fr
Page 122 and 123: Appendix 4. Information for people
Page 124 and 125: 4. Regulatory and legal framework 1
Page 126 and 127: Several protocols have been publish
Page 128 and 129: The coordination of these resources
Page 130 and 131: Social protection systems Pursuant
Page 132 and 133: Specifi c regulation • (SPANISH)
Page 134 and 135: Service Management: The first anti-
Page 136 and 137: on Mental Health and the future Eur
Page 138 and 139: Spanish Society of Legal Psychiatry
Page 140 and 141: Appendix 5. Abbreviations ACT Asser
Page 142 and 143: Appendix 6. Glossary Therapy adhere
Page 146 and 147: 15 Rossler W. Psychiatric rehabilit
Page 148 and 149: 53 Graeber DA, Moyers TB, Griffi th
Page 150 and 151: 86 Schooler NR, Keith SJ, Severe JB
Page 152 and 153: 117 Sohlberg MM, Mateer CA. Effecti
Page 154 and 155: 154 López M, García-Cubillana P,
Page 156 and 157: 190 Bond GR, Drake RE. Predictors o
Page 158 and 159: 225 Hurley AD. Individual psychothe
show all

CPG for Psychosocial Interventions in Severe Mental ... - GuÃ­aSalud

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?

CPG for Psychosocial Interventions in Severe Mental ... - GuÃaSalud